Organization
Wyeth Pharmaceuticals
2 abstracts
Abstract
ADDITIONAL ACR, EULAR, AND DAS28 RESPONSES AT 24 WEEKS IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO WERE NON-RESPONDERS TO COMBINED ETANERCEPT AND METHOTREXATE THERAPY AT 12 WEEKSOrg: Center of Innovative Therapy, Wyeth Pharmaceuticals, Amgen,
Abstract
A NEW APPROACH TO MAXIMISE THE VALUE OF BIOLOGICS IN THE TREATMENT OF RHEUMATOID ARTHRITISOrg: York Health Economics Consortium, University of York, Market Access and Reimbursement, Wyeth Europa, Strategic Planning,